Published in J Immunol on March 01, 2000
Autoimmune T cell responses in the central nervous system. Nat Rev Immunol (2009) 4.73
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res (2007) 3.76
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med (2007) 2.88
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann Neurol (2009) 2.41
Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest (2005) 1.95
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci U S A (2004) 1.91
VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood (2009) 1.59
The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J Clin Immunol (2001) 1.56
Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies. Proc Natl Acad Sci U S A (2005) 1.54
Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. Proc Natl Acad Sci U S A (2004) 1.49
Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol (2005) 1.43
B cell exchange across the blood-brain barrier in multiple sclerosis. J Clin Invest (2012) 1.35
Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity. J Exp Med (2010) 1.29
Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin. J Neuroimmunol (2011) 1.27
Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci U S A (2001) 1.19
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. Sci Transl Med (2014) 1.18
CSF IgG heavy-chain bias in patients at the time of a clinically isolated syndrome. J Neuroimmunol (2008) 1.17
Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol (2010) 1.17
Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One (2008) 1.14
Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc Natl Acad Sci U S A (2002) 1.11
Epstein-barr virus: environmental trigger of multiple sclerosis? J Virol (2007) 1.11
Teriflunomide and its mechanism of action in multiple sclerosis. Drugs (2014) 1.08
Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS. J Neuroimmunol (2007) 1.03
Targeting dendritic cells to treat multiple sclerosis. Nat Rev Neurol (2010) 1.02
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges. Ther Adv Neurol Disord (2013) 1.01
A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroimmunol (2010) 0.99
B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases. Adv Immunol (2008) 0.98
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. J Neuroimmunol (2009) 0.96
Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection. J Neuroimmunol (2006) 0.95
Brain-reactive antibodies and disease. Annu Rev Immunol (2013) 0.94
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review. PLoS One (2013) 0.94
Viruses and multiple sclerosis. Neuroscientist (2011) 0.90
B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage. Autoimmun Rev (2007) 0.90
B cells in multiple sclerosis. Front Biosci (2004) 0.86
Rituximab combination therapy in relapsing multiple sclerosis. Ther Adv Neurol Disord (2012) 0.86
Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis. J Clin Immunol (2005) 0.85
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation. Front Immunol (2015) 0.84
Novel approaches for identifying target antigens of autoreactive human B and T cells. Semin Immunopathol (2009) 0.83
Dendritic cells and multiple sclerosis: disease, tolerance and therapy. Int J Mol Sci (2012) 0.82
Cerebrospinal-fluid-derived immunoglobulin G of different multiple sclerosis patients shares mutated sequences in complementarity determining regions. Mol Cell Proteomics (2013) 0.82
The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing. Front Neurol (2014) 0.81
Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets. Eur Neurol (2015) 0.80
The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data. Hum Vaccin Immunother (2015) 0.80
Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis. Neurol Res Int (2011) 0.78
Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system? Clin Exp Immunol (2012) 0.78
Detection of intrathecal immunoglobulin G synthesis by capillary isoelectric focusing immunoassay in oligoclonal band negative multiple sclerosis. J Neurol (2016) 0.78
MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing. Gene (2015) 0.78
The Ins and Outs of B Cells in Multiple Sclerosis. Front Immunol (2015) 0.78
Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis. Expert Opin Biol Ther (2016) 0.78
Secondary B cell receptor diversification is necessary for T cell mediated neuro-inflammation during experimental autoimmune encephalomyelitis. PLoS One (2013) 0.77
Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments. Mult Scler Int (2015) 0.77
Update on immunopathogenesis and immunotherapy in multiple sclerosis. Immunotargets Ther (2013) 0.75
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis. Ther Adv Neurol Disord (2016) 0.75
High-throughput sequencing of immune repertoires in multiple sclerosis. Ann Clin Transl Neurol (2016) 0.75
Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients. Acta Neuropathol (2016) 0.75
Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence. J Res Med Sci (2017) 0.75
Polyclonal B-cell expansion in the cerebrospinal fluid of patients with pseudotumor cerebri. J Clin Immunol (2004) 0.75
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood (1999) 11.57
Expression of a receptor for IgM by human T cells in vitro. Eur J Immunol (1975) 5.05
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med (2001) 4.83
Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness. J Immunol (1976) 4.64
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest (1998) 3.96
Receptors for IgG molecules on human lymphocytes forming spontaneous rosettes with sheep red cells. Eur J Immunol (1975) 3.26
Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity. J Exp Med (1978) 3.18
Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents. J Immunol (2000) 3.13
Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach. Neurology (2010) 2.48
High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum (2002) 2.45
Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med (1978) 2.39
Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med (1989) 2.16
Stimulation of human B lymphocytes by antibodies to IgM and IgG: functional evidence for the expression of IgG on B-lymphocyte surface membranes. Clin Immunol Immunopathol (1980) 2.00
Induction of polyclonal antibody synthesis by human allogeneic and autologous helper factors. J Exp Med (1979) 1.98
Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J Intern Med (2008) 1.95
Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. J Biol Chem (1988) 1.80
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Mult Scler (2012) 1.74
T cell helper defect in patients with chronic lymphocytic leukemia. J Immunol (1979) 1.74
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler (2006) 1.70
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. Neurology (2011) 1.68
Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nat Med (2001) 1.66
Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia. Immunol Rev (1979) 1.53
The demonstration of acid alpha-naphthyl acetate esterase activity in human lymphocytes: usefulness as a T-cell marker. Cell Immunol (1978) 1.52
Two novel Italian CADASIL families from Central Italy with mutation CGC-TGC at codon 1006 in the exon 19 Notch3 gene. Neurol Sci (2006) 1.51
Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry (2001) 1.51
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology (2010) 1.44
Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis. Results of a preliminary study. Clin Exp Rheumatol (1993) 1.43
Characterization of human T-cell subpopulations as defined by specific receptors for immunoglobulins. Contemp Top Immunobiol (1978) 1.42
Hapten-specific IgE antibody responses in mice. VII. Conversion of IgE "non-responder" strains to IgE "responders" by elimination of suppressor T cell activity. J Immunol (1977) 1.40
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis (2012) 1.40
Conversion of systemic lupus erythematosus to common variable hypogammaglobulinemia. Am J Med (1989) 1.40
Amyloid neuropathy in light chain multiple myeloma. Clin Neuropathol (1989) 1.39
Ultrastructure and cytochemistry of human peripheral blood lymphocytes. Similarities between the cells of the third population and TG lymphocytes. Eur J Immunol (1980) 1.38
Multiple sclerosis and non-communicating syringomyelia: a casual association or linked diseases? Acta Neurol Scand (1999) 1.38
A new strategy for prenatal diagnosis in a sporadic haemophilia B family. Haemophilia (2001) 1.37
Receptors for IgM on certain human B lymphocytes. J Immunol (1977) 1.37
Hapten-specific IgE antibody responses in mice. VI. Selective enhancement of IgE antibody production by low doses of X-irradiation and by cyclophosphamide. J Immunol (1976) 1.36
CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood (1996) 1.35
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia (2013) 1.31
Human T cell receptor for IgM: specificity for the pentameric Fc fragment. Eur J Immunol (1976) 1.30
Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N Engl J Med (1986) 1.29
A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia (2009) 1.27
Human lymphocytes bearing "Ia-like" antigens; absence in patients with infantile agammaglobulinemia. J Immunol (1977) 1.26
Helper factors derived from autologous mixed lymphocyte cultures. Cell Immunol (1980) 1.26
Immunoglobulin heavy chain variable region gene replacement As a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes. J Exp Med (2000) 1.25
The fine structure of subcortical neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropathol (1979) 1.24
Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation. J Immunol (1988) 1.21
In vitro selective expansion of allergen specific T cells from atopic patients. Clin Exp Immunol (1983) 1.21
Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type. Acta Neuropathol (1983) 1.20
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology (2004) 1.20
Progressive supranuclear palsy 1979: an overview. Ital J Neurol Sci (1980) 1.20
Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen. J Clin Invest (1979) 1.19
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med (1995) 1.17
Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. Neurology (2007) 1.16
Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J Pharmacol Exp Ther (1989) 1.16
Large granular lymphocytes in human peripheral blood: ultrastructural and cytochemical characterization of the granules. Blood (1982) 1.16
Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD. Blood (2000) 1.16
Monoclonal antibodies with specificity for hairy cell leukemia cells. J Clin Invest (1982) 1.15
Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule. J Immunol (2000) 1.15
Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type. Clin Immunol Immunopathol (1982) 1.15
Stimulation of a subset of normal resting T lymphocytes by a monoclonal antibody to a crossreactive determinant of the human T cell antigen receptor. J Exp Med (1985) 1.15
Neurological research in Italy in 2003 and 2004. Neurol Sci (2005) 1.13
T cell antigen receptors in autoimmunity. J Immunol (1988) 1.11
Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat Biotechnol (2000) 1.10
Comparison of various tests for Fc receptors on different human lymphocyte sub populations. Clin Exp Immunol (1979) 1.10
Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia. J Immunol (1997) 1.10
Psoriasis and Raynaud's phenomenon associated with autoantibodies to U1 and U2 small nuclear ribonucleoproteins. N Engl J Med (1986) 1.10
Induction of human antibody responses in vitro with emphasis on allogeneic helper factors. Immunol Rev (1979) 1.09
Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas. J Exp Med (1982) 1.09
Selective lysis of the autologous tumor by delta TCS1+ gamma/delta+ tumor-infiltrating lymphocytes from human lung carcinomas. Eur J Immunol (1990) 1.09
Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurology (2004) 1.08
In vitro production of interleukin 1 by normal and malignant human B lymphocytes. J Immunol (1986) 1.08
Regulation of IgE antibody production by serum molecules. I. Serum from complete Freund's adjuvant-immune donors suppresses irradiation-enhanced IgE production in low responder mouse strains. J Immunol (1978) 1.06
Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer. Cancer Res (1995) 1.06
Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response. J Exp Med (1987) 1.05
Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology (2011) 1.04
A study of immunoglobulin classes present on the membrane and in the cytoplasm of human tonsil plasma cells. Eur J Immunol (1976) 1.04
Human T cell lines with antigen specificity and helper activity. Eur J Immunol (1982) 1.04
Fc-receptors for IgG and IgM immunoglobulins on human T lymphocytes: mode of re-expression after proteolysis or interaction with immune complexes. J Immunol (1978) 1.04
Leber's hereditary optic neuropathy (LHON/11778) with myoclonus: report of two cases. J Neurol Neurosurg Psychiatry (2001) 1.03
Clonal expansion is a characteristic feature of the B-cell repetoire of patients with rheumatoid arthritis. Arthritis Res (2000) 1.03
HIV-1 induces down-regulation of bcl-2 expression and death by apoptosis of EBV-immortalized B cells: a model for a persistent "self-limiting" HIV-1 infection. Virology (1994) 1.02
Comparative study of membrane and intracytoplasmic immunoglobulin classes in human lymphoid cells. Ann N Y Acad Sci (1975) 1.01
Borrelia burgdorferi infection and Guillain-Barré syndrome. Lancet (1989) 1.01
An in vitro model for Toxoplasma infection in man. Interaction between CD4+ monoclonal T cells and macrophages results in killing of trophozoites. J Immunol (1988) 1.01
Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas. Leukemia (1999) 1.01